Microba Life Sciences
- Short interest
- 0.10%
- +0.10 pp 30d
- as of 19 June 2026
- Reported shorts
- 700K
- Shares on issue
- 700.308M
Microba Life Sciences (MAP) company profile
Profile, insiders and operations
Company
AI-generated research profile of Microba Life Sciences
Microba Life Sciences is a pioneering company in the health care sector, specializing in advanced microbiome analysis technology. Their innovative approach provides deep insights into gut health, enabling precision diagnostics and personalized treatment plans. With a strong focus on scientific rigor and evidence-based solutions, Microba is positioned as a leader in microbiome research and diagnostics.
Director trades
20 trades recorded
Who owns it
2 substantial holders disclosing 30.41%; held by 0 index ETFs and 1 super fund option tracked
| Holder | Kind | Voting power | Change | As at | Notice |
|---|---|---|---|---|---|
| Sonic Healthcare Limited | Listed company | 21.68% | +1.69 pp | 2025-08-13 | |
| Mercer Investments | Super fund | 8.725% | +1.14 pp | 2026-09-30 |
Index funds and super funds
| Fund | Value | Of shares | Of fund | As at |
|---|---|---|---|---|
| Mercer SuperMercer Growth | $76.2K | n/a | <0.01% | 2026-06-30 |
From ASX substantial holding notices (5% or more), index ETF holdings files and super fund portfolio holdings disclosures. Holders' interests can overlap. How ownership is read.
MAP intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links